Umbilical artery catheters in the newborn: effects of heparin
Open Access
- 25 January 1999
- journal article
- review article
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 1999 (2), CD000507
- https://doi.org/10.1002/14651858.cd000507
Abstract
This section is under preparation and will be included in the next issue. To determine whether the use of heparin in fluids infused through an umbilical arterial catheter in newborn infants influences the frequency of clinical ischemic events, catheter occlusion, aortic thrombosis, intraventricular hemorrhage, hypertension, death, or the duration of catheter usability. Randomized and quasi randomized controlled trials of umbilical catheterization use were obtained from the following sources: 1. Effective Care of the Newborn Infant, edited by JC Sinclair and MB Bracken. 2. Medline Search using Melvyl Medline Plus and the keyword headings 'Umbilic#', 'Catheter#' and subject heading 'Infant, Newborn' 3. Search of personal data files Randomized trials in newborn infants of any birthweight or gestation. Comparison of heparinised to non heparinised infusion fluids, including comparison of heparin in the infusate to heparin just in the flush solution. Clinically important end points such as catheter occlusion or aortic thrombosis. There were five randomized controlled trials retrieved. All gave details of the incidence of catheter occlusion. Two also reported the incidence of aortic thrombosis. The intervention was reasonably consistent: heparin in the infusate at a concentration of 1 unit/mL was investigated in all trials except one which used a concentration of 0.25 units/mL. Studies generally included both term and preterm infants. Heparinization of the infusate decreases the incidence of catheter occlusion but does not affect the frequency of aortic thrombosis. Heparinization of the flush solution is not an adequate alternative. There does not appear to be an effect on frequency of intraventricular hemorrhage, death or clinical ischemic phenomena. Heparinization of the fluid infused through an umbilical arterial catheter decreases the likelihood of umbilical arterial catheters occluding. The lowest concentration tested so far (0.25 units/mL) has been shown to be effective. Heparinization of flushes without heparinizing the infusate is ineffective. The frequency of aortic thrombosis has not been shown to be affected; however, the confidence intervals for this effect are very wide. The frequency of intraventricular hemorrhage has not been shown to be affected by heparinization of the infusate, but again the confidence intervals are very wide and even a major increase in the incidence of grade 3 and 4 intraventricular hemorrhage would not have been detected.Keywords
This publication has 11 references indexed in Scilit:
- Umbilical artery catheters in the newborn: effects of heparinCochrane Database of Systematic Reviews, 1999
- Heparin and the risk of intraventricular hemorrhage in premature infantsThe Journal of Pediatrics, 1997
- The association of heparin exposure with intraventricular hemorrhage among very low birth weight infants.1995
- Effect of Adding Heparin in Very Low Concentration to the Infusate to Prolong the Patency of Umbilical Artery CathetersAmerican Journal of Perinatology, 1993
- Effect of heparin infusates in umbilical arterial catheters on frequency of thrombotic complicationsThe Journal of Pediatrics, 1987
- Heparin Use as a Risk Factor for Intraventricular Hemorrhage in Low-Birth-Weight InfantsNew England Journal of Medicine, 1986
- Continuous versus intermittent heparin infusion of umbilical artyery catheters in the newborn infantThe Journal of Pediatrics, 1986
- HEPARIN PREVENTION OF CATHETER RELATED THROMBOSESPediatric Research, 1984
- Prevention of Umbilical Artery Catheter Clots with Heparinized InfusatesDevelopmental Pharmacology and Therapeutics, 1981
- Effect of Heparinization of Fluids Infused Through an Umbilical Artery Catheter on Catheter Patency and Frequency of ComplicationsPediatrics, 1979